Novelos Therapeutics is a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer. The company’s portfolio includes: I-124-CLR1404, currently in phase 1-2 clinical trials; I-131-CLR1404, in phase 1b dose-escalation trial; CLR1502, a small-molecule optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging; and CLR1404, a pre-clinical cancer-targeted nonradioactive chemotherapy. For more information visit the company’s Web site at www.novelos.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: